DE602005024151D1 - Antibakterielle mittel - Google Patents

Antibakterielle mittel

Info

Publication number
DE602005024151D1
DE602005024151D1 DE602005024151T DE602005024151T DE602005024151D1 DE 602005024151 D1 DE602005024151 D1 DE 602005024151D1 DE 602005024151 T DE602005024151 T DE 602005024151T DE 602005024151 T DE602005024151 T DE 602005024151T DE 602005024151 D1 DE602005024151 D1 DE 602005024151D1
Authority
DE
Germany
Prior art keywords
antibacterial agents
quinoxaline
quinoline
mammals
naphthalene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE602005024151T
Other languages
German (de)
English (en)
Inventor
William Henry Miller
Mark Andrew Seefeld
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of DE602005024151D1 publication Critical patent/DE602005024151D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/397—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having four-membered rings, e.g. azetidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DE602005024151T 2004-08-02 2005-08-02 Antibakterielle mittel Expired - Lifetime DE602005024151D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US59818004P 2004-08-02 2004-08-02
PCT/US2005/027348 WO2006017468A2 (en) 2004-08-02 2005-08-02 Antibacterial agents

Publications (1)

Publication Number Publication Date
DE602005024151D1 true DE602005024151D1 (de) 2010-11-25

Family

ID=35839845

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602005024151T Expired - Lifetime DE602005024151D1 (de) 2004-08-02 2005-08-02 Antibakterielle mittel

Country Status (6)

Country Link
US (1) US7655648B2 (enExample)
EP (1) EP1781669B1 (enExample)
JP (1) JP2008508359A (enExample)
AT (1) ATE484509T1 (enExample)
DE (1) DE602005024151D1 (enExample)
WO (1) WO2006017468A2 (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7263501B2 (en) 2003-03-11 2007-08-28 I-Stat Corporation Point-of-care inventory management system and method
WO2006081179A1 (en) * 2005-01-25 2006-08-03 Glaxo Group Limited Antibacterial agents
EP1790342A1 (de) 2005-11-11 2007-05-30 Zentaris GmbH Pyridopyrazin-Derivate und deren Verwendung als Modulatoren der Signaltransduktionswege
US8217042B2 (en) 2005-11-11 2012-07-10 Zentaris Gmbh Pyridopyrazines and their use as modulators of kinases
EP2007377A4 (en) 2006-04-06 2011-08-17 Glaxo Group Ltd ANTIBACTERIAL ACTIVE SUBSTANCES
DE602007009205D1 (de) 2006-04-06 2010-10-28 Glaxo Group Ltd Pyrrolochinoxalinonderivate als antibakterielle mittel
AU2007268749B2 (en) 2006-05-26 2012-07-26 Taisho Pharmaceutical Co., Ltd. Novel heterocyclic compound or salt thereof and intermediate thereof
EP1992628A1 (en) 2007-05-18 2008-11-19 Glaxo Group Limited Derivatives and analogs of N-ethylquinolones and N-ethylazaquinolones
WO2008128942A1 (en) * 2007-04-20 2008-10-30 Glaxo Group Limited Tricyclic nitrogen containing compounds as antibacterial agents
EP2080761A1 (en) 2008-01-18 2009-07-22 Glaxo Group Limited Compounds
JP2012505866A (ja) 2008-10-17 2012-03-08 グラクソ グループ リミテッド 抗菌剤として使用される三環式窒素化合物
JP5653935B2 (ja) 2009-01-15 2015-01-14 グラクソ グループ リミテッドＧｌａｘｏ Ｇｒｏｕｐ Ｌｉｍｉｔｅｄ 抗菌薬として有用なナフチリジン―２（１ｈ）−オン化合物
AR101674A1 (es) 2014-08-22 2017-01-04 Glaxosmithkline Ip Dev Ltd Uso de un compuesto tricíclico que contiene nitrógeno
UY36851A (es) 2015-08-16 2017-03-31 Glaxosmithkline Ip Dev Ltd Compuestos para uso en aplicaciones antibacterianas

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2634483B2 (fr) * 1987-12-29 1994-03-04 Esteve Labor Dr Derives des acides 7-(1-azetidinyl)-1,4-dihydro-4-oxoquinoleine-3-carboxyliques, leur preparation et leur application en tant que medicaments
US5162523A (en) * 1989-07-21 1992-11-10 Hoffmann-La Roche Inc. Cephalosporin antibacterial compounds
JP2004504397A (ja) 2000-07-26 2004-02-12 スミスクライン　ビーチャム　パブリック　リミテッド　カンパニー 抗菌活性を有するアミノピペリジンキノリン類およびそれらのアザイソステリックアナログ類
GB0101577D0 (en) 2001-01-22 2001-03-07 Smithkline Beecham Plc Compounds
WO2003064431A2 (en) 2002-01-29 2003-08-07 Glaxo Group Limited Aminopiperidine compounds, process for their preparation, and pharmaceutical compositions containing them
JP4445753B2 (ja) * 2002-01-29 2010-04-07 グラクソ グループ リミテッド アミノピペリジン誘導体
US6995144B2 (en) * 2002-03-14 2006-02-07 Eisai Co., Ltd. Nitrogen containing heterocyclic compounds and medicines containing the same
AR040336A1 (es) 2002-06-26 2005-03-30 Glaxo Group Ltd Compuesto de piperidina, uso del mismo para la fabricacion de un medicamento, composicion farmaceutica que lo comprende y procedimiento para preparar dicho compuesto
WO2004055012A1 (en) 2002-12-13 2004-07-01 Smithkline Beecham Corporation Indane compounds as ccr5 antagonists
AR042486A1 (es) 2002-12-18 2005-06-22 Glaxo Group Ltd Compuesto de quinolina y naftiridina halosustituido en la posicion 3, procedimiento para preparar el compuesto, composicion farmaceutica que lo comprende y su uso para preparar dicha composicion .
TW200507841A (en) 2003-03-27 2005-03-01 Glaxo Group Ltd Antibacterial agents
WO2004092177A1 (en) 2003-04-09 2004-10-28 Biogen Idec Ma Inc. Triazolopyrazines and methods of making and using the same
US7550485B2 (en) 2003-10-14 2009-06-23 Wyeth Substituted N-heterocycle derivatives and methods of their use
US7691850B2 (en) 2004-06-15 2010-04-06 Glaxo Group Limited Antibacterial agents
JP2008506695A (ja) * 2004-07-13 2008-03-06 グラクソ　グループ　リミテッド 抗細菌剤
EP1784410A4 (en) * 2004-08-09 2009-07-15 Glaxo Group Ltd ANTIBACTERIAL AGENTS

Also Published As

Publication number Publication date
ATE484509T1 (de) 2010-10-15
JP2008508359A (ja) 2008-03-21
US7655648B2 (en) 2010-02-02
US20070244091A1 (en) 2007-10-18
EP1781669A2 (en) 2007-05-09
EP1781669A4 (en) 2009-03-11
WO2006017468A2 (en) 2006-02-16
EP1781669B1 (en) 2010-10-13
WO2006017468A3 (en) 2006-07-13

Similar Documents

Publication Publication Date Title
DE60334016D1 (de) Antibakterielle mittel
TW200507841A (en) Antibacterial agents
WO2006002047A3 (en) Antibacterial agents
WO2004058144A3 (en) Antibacterial agents
DE60331849D1 (de) Antibakterielle wirkstoffe
ATE344799T1 (de) Piperidinderivate als antibakterielle mittel
WO2006020561A3 (en) Antibacterial agents
WO2007016610A3 (en) Antibacterial agents
WO2007118130A3 (en) Antibacterial agents
PE20001112A1 (es) Derivados de quinolina como agentes antibacterianos
WO2006081289A3 (en) Antibacterial agents
AU2003251474A8 (en) Aminocyclohexene quinolines and their azaisosteric analogues with antibacterial activity
ATE255104T1 (de) Quinolin-derivate und deren verwendung als antibakterielle wirkstoffe
ATE484509T1 (de) Antibakterielle mittel
DE602004021644D1 (de) Gyraseinhibitoren und deren verwendungen
WO2006010040A3 (en) Antibacterial agents
DE60324179D1 (de) Chinoline und stickstoffhaltige derivatedavon und deren verwendung als antibakterielle mittel
NO20052362D0 (no) Fremgangsmater for administrering av dalbavancin for behandling av bakterielle infeksjoner
ATE354585T1 (de) Antibakterielle amid-makrozyklen
WO2006081182A3 (en) Antibacterial agents
NO20072890L (no) Behandling av mastitt
WO2006081178A3 (en) Antibacterial agents
ATE495186T1 (de) Antibakterielle amid-makrozyklen iv
ATE433459T1 (de) Desoxo-nonadepsipeptide
WO2005118613A3 (de) Antibakterielle amid-makrozyklen